Nucala 100 mg powder for solution for injection, IMUREL 25 mg, comprimé pelliculé, CYCLOPHOSPHAMIDE, SODIUM CHLORIDE, PLACEBO D AZATHIOPRINE
D20180135
Phase 3 small_molecule active
Quick answer
Nucala 100 mg powder for solution for injection, IMUREL 25 mg, comprimé pelliculé, CYCLOPHOSPHAMIDE, SODIUM CHLORIDE, PLACEBO D AZATHIOPRINE for Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active